🇮🇳IN
Sign In
MA

MANGALAM

NSE

Mangalam Drugs And Organics Limited

₹27.49

-1.07(-3.75%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector−₹5,497 Crnet foreign selling
2026-10-01 to 2026-10-15

This is the flow into the whole Healthcare sector, not into MANGALAM. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

MANGALAM exposure summary

Mangalam Drugs And Organics Limited reports a single business segment, Manufacture of Bulk Drugs.

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer